Large Cap Biopharmaceutical Metrics and Performance Q1 2025
Large Cap Biopharmaceuticals- Performance Metrics The best performing biopharma stocks YTD were: ABBV up 8.5%, AMGN up 11.8%, AZN up 12%, GILD up 12.7%, LLY up 9.4%, VRTX up 14%. The worst performing biopharmas YTD were: BMY down 4.7%, BIIB, down 10.2%, MRK down 16.6%, PFE. down 3.7%, REGN down...
SMID Biotech Stocks had a Good Week despite crosscurrents
SMID Biotech Stocks Rallied Nicely the Week of 2/13/25 Selected SMID life science stocks had a good week in a bifurcated market. Large cap biopharmas earnings have been strong and comprise the largest healthcare holdings in our portfolio. Political crosscurrents are a concern- uncertainty of...
BIG Hurricane season forecasted– LA Nina has Ended… Update 6/12/25
Update 6/11/25 Can AI replace the weatherman? NOAA Predicts the Most Hurricanes That It Has Ever Forecast Up to 25 tropical storms and as many at 13 hurricanes are expected to form....
Healthcare and Biotech Playbook as Disruption Gathers Force…Update-3. Focus on SMIDs
Update-3 ....2/14/25...Happy Valentine's Day!... RISK ON for MOMENTUM Trades in SMID Life Science List.-Big MOVERS: ABSI, ARKG, BBIO, CRSP, DNLI,,GH, MNMD,PACB, RXRX,TEM, VCYT. We missed TEM up 29% in 5 days. Jumped into REGN too soon down 4.57% In 5 days. Update-2 ...2/12/25....The market is...
Can Biotech Stocks Survive the Precarious Macro?…Update-2…SMID weakness
Update-2 ...2/7 1;30 EST Risk off for SMID biotech caps on MACRO news and technicals. XBI down 2%.Renewed tariff threats. BIG tech feeling the heat on CHINA trade war? Consumer sentiment hits 7 month low. Update-1 2/4/25 315p EST...Nice little rally in biotech and MedTech: ABBV, LLY, RHHBY,...